Achieve Life $ACHV Up 22% 

CorMedix $CRMD Up 15%

Tyme Tech $TYME Up 45%

Join for Free now! Limited Time Offer!

Aphria, APHA, Company Profile, Business Summary

Aphria a Success Story, Canadian Pot going mainstream, pushing the boundaries, Legal Pot meets High Finance. Aphria has successfully transitioned to New York Stock Exchange from OTCQB.

Aphria is a leading global cannabis company, headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities, bringing breakthrough innovation to the global cannabis market. Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.

Key Operating Highlights

• 92% increase in kilogram equivalents1 sold, reflecting partial period sales from the opening of the Canadian adult-use market, as well as continued sales of medical cannabis to existing and new patients
• Adjusted gross margins of 47% of net revenue, compared to 64% in prior quarter, as expected, due to lower effective selling prices in adult-use market, as well as temporarily lowered yields and higher production costs related to facilities expansion and implementation of automation
• Part IV and V expansions of Aphria One awaiting Health Canada approval; application for cultivation licence at Aphria Diamond submitted and also awaiting Health Canada pre-cultivation inspection
• Announced and closed subsequent to quarter-end of the acquisition of CC Pharma, a leading distributor to pharmacies in Germany
• Closed acquisition of key operations and licenses in strategic Latin America and Caribbean jurisdictions; subsequently established additional strategic alliances in the region to expand the Company's medical cannabis operations and distribution
• Listed on the NYSE, providing shareholders greater liquidity
• Appointed new independent Chair of Board of Directors, Irwin D. Simon, subsequent to quarter-end
• Ended quarter with strong balance sheet and liquidity, including $152.1 million of cash and $32.7 million of liquid marketable securities, to fund announced Canadian and International growth and facilities expansion

Executive Transition

Aphria Chief Executive Officer Vic Neufeld, and Co-founder Cole Cacciavillani, are both nearing the end of their five-year journey with the Company and will transition out of their executive roles over the coming months but remain on the Board. Working closely with Irwin D. Simon, Aphria's recently appointed independent Chair, and President Jakob Ripshtein, Mr. Neufeld and Mr. Cacciavillani intend to complete a smooth and responsible transition to a globally-minded executive leadership team for the long-term benefit of the Company's patients, shareholders, customers, and employees.

Aphria Chair Irwin D. Simon commented, "Vic and Cole are consummate entrepreneurs. Thanks to their vision, energy and passion, Aphria has become a global player in an industry that didn't even exist five years ago. On behalf of the entire Aphria team, I want to express my gratitude to both. I look forward to working with them to further build Aphria's leadership team and continue driving long-term value for our patients, customers and employees into the future."

"When the Canadian medical cannabis market opened up five years ago, Cole was growing millions of potted flowers in Leamington, and he understood that cannabis was a natural product extension for the founding team's decades of experience as greenhouse growers in Leamington," said Mr. Neufeld. "Now with legalization and globalization, including a huge market opportunity with positive developments in the U.S., Aphria's next generation of leadership may take the reins. Building and leading a Company like Aphria, which exploded from an idea in late 2013 to our many successes to-date, has been an incredible journey, despite the toll it has taken on health, family and personal priorities."

"Vic and I have worked tirelessly for decades, building great businesses, but now in our sixties, it is time for both of us to step back from the demands of leading a world-class organization. Endless meetings, travel, deadlines, talent search - the list of executive responsibilities will only continue to grow," said Mr. Cacciavillani.

"Succession is the plan. Cole and I have informed the Board, and they have agreed, that we will begin the transition process immediately, and at the appropriate time, we will both step down from executive positions at Aphria. We continue to have the greatest pride in what Aphria has achieved, and its future has never looked brighter. From continued technology advancements, to continued support of scientific developments, to amazing adult-use brands, to globalization strategies, and most of all, the hundreds of dedicated passionate team members that have joined Aphria, we are well positioned to be a dominant player," concluded Mr. Neufeld.

The Board has requested that, following the transition, Mr. Neufeld and Mr. Cacciavillani continue to apply their knowledge and expertise as special advisors to both the Chair and the President, ensuring a smooth transition of institutional experience and strategic advice until a new CEO is appointed.

Source: The Company, OxBridge Research, Daily Stock Deals, OTC Stock Wire

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® Disclaimer/Disclosure: we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks. 

If you want to get your company featured on Daily Stock Deal or want to learn more, please contact the Editor. Thanks you!

EMES                   SIFY               HOS                 CXDC                 EGY                TMDI          

11.56%               6.71%             5.59%              12.14%               7.14%             21.83%       

 MDXG              VTVT               VHC                   PLUG

 15.28%           31.65%            65.33%              4.58%

Limited time FREE Membership. Join today! 

Discover great trading opportunities, rare finds, least followed stocks, excellent opportunity for value investors, discerning day and position traders, start your trading day with our picks, every day!  FREE Deals, Join Thousands of Smart Investors, it takes only 17 seconds! Click here!

Hot Stocks to Watch, $NMRD, $XBIT, $NOG, $GOGO

GOGO Inc, $GOGO, gathering momentum, high volume, in a positive territory for the quarter.

The Company is a provider of in-flight broadband connectivity and connectivity-enabled services to commercial and business aviation.

XBiotech,  $XBIT, bouncing back from 52WK Lows, huge volume.

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer.

Nemaura Medical, $NMRD, Surging on positive data on SurgeBEAT.

SugarBEAT® is expected to launch in the UK in the coming months, and is expected to be marketed to all categories of diabetics, including Type 1, Type 2 and pre-diabetics. Continuous Glucose Monitoring (CGM) is estimated to have a global total addressable market worth $82Bn. The U.S. has the largest number of CGM users, where 2018 usage numbers are estimated at 630,000 insulin users, representing 2.6% of 24.6 million people who have been diagnosed with diabetes.2.

Northern Oil & Gas, $NOG, accelerating on higher Gas & Oil production.

Norther Oil, is an independent energy company. The Company is engaged in exploration, development and production of oil and natural gas in the Bakken and the Williston Basin in North Dakota and Montana.